Maria Papadoliopoulou, Spyridon Koutsoumpos, Ioannis Margaris, Maria Matiatou, Panagiotis Giannios, Nikolaos Arkadopoulos, Konstantinos Moutzouris, Nikolaos V Michalopoulos
{"title":"Real Index of Refraction of Normal and Cancerous Axillary Lymph Nodes in Breast Cancer Patients: Results from an Experimental Study.","authors":"Maria Papadoliopoulou, Spyridon Koutsoumpos, Ioannis Margaris, Maria Matiatou, Panagiotis Giannios, Nikolaos Arkadopoulos, Konstantinos Moutzouris, Nikolaos V Michalopoulos","doi":"10.3390/jpm15020071","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Breast malignancy is the most common cancer type and the second leading cause of cancer-related death for women all ages. Axillary surgery provides prognostic and predictive information, but carries significant morbidity. Imaging techniques are a promising field, providing the characterization of biological tissues using the interaction between the light and a medium, and may offer an accurate cancerous diagnosis without the need for formal histopathological examination. <b>Methods:</b> In this study, using a prism couple refractometer, we sought to determine tissues' reflection profiles in freshly excised human lymph nodes from female patients with breast cancer, in whom axillary lymph node dissection was performed. <b>Results:</b> Thirty-four patients were included, contributing a total number of 90 lymph nodes and, according to our results, the median refractive indices were significantly higher in cancerous lymph nodes compared to normal lymph nodes in 450 nm, 964 nm, and 1551 nm wavelengths (<i>p</i> < 0.05). <b>Conclusions:</b> Results from this small experimental study imply that the use of a prism couple refractometer may aid in the discrimination between benign and malignant axillary lymph nodes in female patients with breast cancer.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"15 2","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm15020071","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Breast malignancy is the most common cancer type and the second leading cause of cancer-related death for women all ages. Axillary surgery provides prognostic and predictive information, but carries significant morbidity. Imaging techniques are a promising field, providing the characterization of biological tissues using the interaction between the light and a medium, and may offer an accurate cancerous diagnosis without the need for formal histopathological examination. Methods: In this study, using a prism couple refractometer, we sought to determine tissues' reflection profiles in freshly excised human lymph nodes from female patients with breast cancer, in whom axillary lymph node dissection was performed. Results: Thirty-four patients were included, contributing a total number of 90 lymph nodes and, according to our results, the median refractive indices were significantly higher in cancerous lymph nodes compared to normal lymph nodes in 450 nm, 964 nm, and 1551 nm wavelengths (p < 0.05). Conclusions: Results from this small experimental study imply that the use of a prism couple refractometer may aid in the discrimination between benign and malignant axillary lymph nodes in female patients with breast cancer.
期刊介绍:
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.